Showing results (111-120 of 132) with videos related to
Sort By:
Pageof 14
Oncotarget|July 10, 2018
Ipilimumab plus nivolumab and DNA-repair defects in AR-V7-expressing metastatic prostate cancerKarim Boudadi, Daniel L Suzman, Valsamo Anagnostou, et al.Nature Medicine|November 9, 2021
Durvalumab with platinum-pemetrexed for unresectable pleural mesothelioma: survival, genomic and immunologic analyses from the phase 2 PrE0505 trialPatrick M Forde, Valsamo Anagnostou, Zhuoxin Sun, et al.Journal for Immunotherapy of Cancer|March 29, 2020
Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization ProjectDiana M Merino, Lisa M McShane, David Fabrizio, et al.Biorxiv : the Preprint Server for Biology|July 10, 2023
Elucidating the heterogeneity of immunotherapy response and immune-related toxicities by longitudinal ctDNA and immune cell compartment tracking in lung cancerJoseph C Murray, Lavanya Sivapalan, Karlijn Hummelink, et al.Journal for Immunotherapy of Cancer|September 15, 2020
Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancerJoshua E Reuss, Valsamo Anagnostou, Tricia R Cottrell, et al.Nature Communications|May 20, 2022
Automated next-generation profiling of genomic alterations in human cancersLaurel A Keefer, James R White, Derrick E Wood, et al.Cancer Discovery|June 9, 2022
Human Colon Cancer-Derived Clostridioides difficile Strains Drive Colonic Tumorigenesis in MiceJulia L Drewes, Jie Chen, Nicholas O Markham, et al.The Journal of Experimental Medicine|November 22, 2022
Intelectin-1 binds and alters the localization of the mucus barrier-modifying bacterium Akkermansia muciniphilaJuan D Matute, Jinzhi Duan, Magdalena B Flak, et al.Nature Medicine|March 20, 2024
Neoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal/gastroesophageal junction cancer: a phase Ib trial and ctDNA analysesRonan J Kelly, Blair V Landon, Ali H Zaidi, et al.Proceedings of the National Academy of Sciences of the United States of America|December 10, 2014
Microbiota organization is a distinct feature of proximal colorectal cancersChristine M Dejea, Elizabeth C Wick, Elizabeth M Hechenbleikner, et al.Pageof 14